As per the latest report by IMARC Group,finds that the global neurodegenerative disease treatment market size reached US$ 40.90 Billion in 2020. Neurodegenerative diseases primarily affect the peripheral nervous system (PNS) or neurons in the human brain.

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Neurodegenerative
Disease Treatment Market
Research Report and
Forecast 2021-2026
Author: Elena Anderson,
Marketing Manager |
IMARC Group
© 2019 IMARC All Rights Reserved

2. Report Description
About IMARC Group
The International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all sectors
and regions to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report Description
Report Description and Highlights
Global Neurodegenerative Disease Treatment Market Outlook 2026:
According to the recent report by IMARC Group, titled “Neurodegenerative Disease Treatment Market:
Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” finds that the
global neurodegenerative disease treatment market size reached US$ 40.90 Billion in 2020.
Neurodegenerative diseases primarily affect the peripheral nervous system (PNS) or neurons in the
human brain. They are incurable diseases that lead to progressive degeneration of the structure that is
essential for mobility, coordination, strength, sensation and cognition.
They are majorly caused by the deposition of toxic proteins in the brain, obstructing the normal
functioning of mitochondria in the brain. Alzheimer’s, Parkinson’s, and Huntington’s are the common
neurodegenerative diseases that cause permanent loss of neurons and are considered genetic,
following the autosomal dominant pattern of inheritance.
However, there are treatments that help relieve some of the physical or mental symptoms associated
with these diseases. The treatment is mainly based on biomarkers and imaging spectrometry, which
aids in the detection of the disease at an early stage and prevents progression.

4. Report Description
Report Description and Highlights
Global Neurodegenerative Disease Treatment Market Trends:
The global neurodegenerative disease treatment market is primarily driven by the rising prevalence of
neurological disorders, especially among the geriatric population. The number of new cases has
increased in recent years due to the growth in population and their average lifespan.
The market is further propelled by the growing awareness among the masses via various health
education campaigns organized by governmental and non-governmental organizations (NGOs) about
the benefits of neurodegenerative disease treatments.
This has prompted manufacturers to invest in the research and development (R&D) activities for the
development of minimally invasive (MI) screening tests and neuropathological methods that facilitate
the classification of these diseases.
Moreover, the introduction of molecular diagnostic methods for the detection of these diseases is also
positively impacting the market growth.
Request for a free sample report: https://www.imarcgroup.com/neurodegenerative-disease-
treatment-market/requestsample

5. Market Summary:
Breakup by Indication:
• Multiple sclerosis
• Parkinson’s disease
• Alzheimer’s disease
• Spinal muscular atrophy (SMA)
• Huntington’s disease
Breakup by Drug Type:
• Selective serotonin reuptake inhibitors
• N-methyl-D-aspartate receptor antagonists
• Dopamine inhibitors
Breakup by Route:
• Oral
• Injectable
• Others
Report Description
Report Description and Highlights

6. Breakup by Application:
• Hospital pharmacies
• Retail pharmacies
Breakup by Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
On account of these factors, the market is expected to exhibit a CAGR of 7.50% during the forecast
period (2021-2026).
Report Description
Report Description and Highlights

7. Competitive Landscape With Keyplayer:
• Biogen Inc
• Boehringer Ingelheim International GmbH
• F. Hoffmann-La Roche AG
• GlaxoSmithKline Plc, Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi S.A
• Teva Pharmaceutical Industries Ltd.
• UCB S.A.
View Report TOC, Figures and Tables : https://www.imarcgroup.com/neurodegenerative-disease-
treatment-market
Report Description
Report Description and Highlights

8. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

9. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

10. Report Description
Report Description and Highlights
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

11. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us